Insider · CIK 0002094238
Juan Sanchez
Files at NVCT (Nuvectis Pharma, Inc.). First filing Nov 6, 2025, latest Nov 6, 2025.
In brief
Juan Sanchez files SEC Form 4 as director at NVCT (Nuvectis Pharma, Inc.). Since Nov 6, 2025, Juan Sanchez has reported 1 open-market buy worth $75k and 0 open-market sells worth $0, the latest filed on Nov 6, 2025.
A track record needs three past buys with six months of prices behind them; Juan Sanchez has 0, so none is measured yet.
The newest scored trade: bought $75k of NVCT on Nov 5, 2025, filed Nov 6, 2025, scored 49 (moderate). In the last 12 months: 1 buy worth $75k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVCT: Nuvectis Pharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Nuvectis Pharma, Inc. | $75k 13,000 shares | +20% | +25% from low-49% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 113,380 | Jun 12, 2026 |
| Nov 5, 2025 | NVCT Nuvectis Pharma, Inc. | POpen-market purchase Common Stock | +13,000 | $5.79 | $75k | 78,150 | Nov 6, 2025 |
| Sep 22, 2025 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 65,150 | Oct 31, 2025 |
Questions about Juan Sanchez
Answered from the filings on this page, as of the latest one.
Is Juan Sanchez buying or selling?
In the last 12 months Juan Sanchez reported 1 open-market buy worth $75k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $75k of NVCT on Nov 5, 2025. Grants, option exercises and tax withholding are not counted.
How did Juan Sanchez's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Juan Sanchez has 0.
Where does Juan Sanchez file Form 4?
Juan Sanchez has filed Form 4 at NVCT (Nuvectis Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.